Reducing Early Readmission to an Acute Psychiatric Unit
Launched by FUNDACIÓN PÚBLICA ANDALUZA PARA LA INVESTIGACIÓN DE MÁLAGA EN BIOMEDICINA Y SALUD · Sep 18, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on reducing the number of patients who have to return to a psychiatric unit shortly after being discharged. Early readmissions can make recovery harder for individuals dealing with mental health issues, so the study is testing a new program designed to help patients transition smoothly from the hospital to their everyday lives. The program includes evaluating each patient’s risk of readmission and providing tailored support, especially for those at higher risk. For patients identified as high-risk, there will also be a group therapy option to help them adjust and recover after leaving the hospital.
To participate in this trial, individuals should be legal adults who speak Spanish and have recently been admitted to the psychiatric unit at the Regional Hospital of Málaga with a high risk for readmission. It's important to note that those with certain substance use disorders or significant intellectual disabilities will not be eligible. Participants can expect personalized care and support to help them manage their mental health after discharge, along with being part of a group that fosters recovery and well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All hospital admission episodes at MHHU during the 12 months following the implementation of the Discharge Transition Intervention Program will be considered.
- • The experimental group, to which the Discharge Transition Intervention Program will be applied, will consist of users whose Community Mental Health Units (CMHU) are affiliated with the Regional Hospital of Málaga.
- Exclusion Criteria:
- • • Users belonging to other hospitals in the province will be excluded from the intervention program and will form part of the control group.
- Post-Discharge Group Psychotherapy Support Recovery has its own eligibility criteria:
- Inclusion criteria:
- • Be of legal age.
- • Speak spanish fluently.
- • Have had recent admission to the MHHU of the Regional Hospital of Málaga and a score considered as "High Risk" on the Early Rehospitalization Risk Scale or have experienced an early rehospitalization.
- • Belong to the Clinical Management Unit of Mental Health of the RUH of Málaga.
- • Have sufficient cognitive capacity to understand the rules and contents of the group intervention.
- Exclusion criteria:
- • Individuals whose primary diagnosis is a Mental and Behavioral Disorder due to psychoactive substance use.
- • Moderate or severe intellectual disability.
- • Clinical Management Unit belonging to a hospital other than the RUH of Málaga.
- • Lack of commitment to attending sessions or complying with group rules.
About Fundación Pública Andaluza Para La Investigación De Málaga En Biomedicina Y Salud
The Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud is a prominent public foundation dedicated to advancing biomedical research and health initiatives in the Andalusia region of Spain. Committed to fostering innovation and collaboration, the foundation supports a wide array of clinical trials aimed at improving health outcomes and enhancing scientific knowledge. By integrating cutting-edge research with clinical practice, it strives to contribute significantly to the development of new therapeutic strategies and health solutions, ultimately benefiting patients and the broader healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Málaga, , Spain
Patients applied
Trial Officials
Vera Carbonell Aranda, Bachelor
Principal Investigator
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported